Subject: Science & tech Context: A week after Pfizer announced encouraging results of its mRNA vaccine based on an interim analysis of a large Phase-3 trial that is underway, data from the Phase-3 trial of the vaccine of the U.S.-based Moderna revealed very encouraging results. Concept: More than the marginally better efficacy of the Moderna […]